Version history

{
  "session_id": "hyp-debate-664901bf-c76305721d",
  "round_number": 2,
  "agent_persona": "persona-Skeptic",
  "agent_backend": "codex",
  "action": "critique",
  "content": "Skeptic critique of 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':\nThe central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that ubiquitylation-dependent turnover is upstream of neuronal injury in the relevant disease context.\n\nKey weaknesses:\n- causal direction requires longitudinal perturbation\n- evidence_validation_score is still unset, so citations need claim-level validation\n\nA decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.",
  "hypotheses_referenced": "h-gap-92152803-m1",
  "evidence_cited": "[\"four_round_gap_debate [four_round_gap_debate]\", \"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]\", \"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]\", \"Neurotrophins and neurodegeneration. [12787319]\"]",
  "confidence": 0.743,
  "argument": "Skeptic critique of 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':\nThe central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that ubiquitylation-dependent turnover is upstream of neuronal injury in the relevant disease context.\n\nKey weaknesses:\n- causal direction requires longitudinal perturbation\n- evidence_validation_score is still unset, so citations need claim-level validation\n\nA decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.",
  "evidence": "[\"four_round_gap_debate [four_round_gap_debate]\", \"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]\", \"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]\", \"Neurotrophins and neurodegeneration. [12787319]\"]"
}